Matthew Herder and colleagues critically analyze the basis upon which Health Canada approved OxyContin.

Matthew Herder and colleagues critically review the regulatory history of buprenorphine formulations in Canada.

Matthew Herder and colleagues publish on the topic of fair pricing and Canada's orphan drug policy.

Françoise Baylis publishes a blog on ethical issues regarding heritable human genome editing.

Françoise Baylis, Seema Mohapatra, and Natalie Kofler discuss concerns about the scientific, ethical, and practical risks associated with the broad use of COVID-19 vaccine credential programs, including racial discrimination and inequity at the hands of others.

Matthew Herder, Alexander C. Egilman, and Joseph S. Ross discuss Health Canada's release of clinical information, how use of the data to date appears low and why increased use of these data could be invaluable.

Françoise Baylis with colleagues from a WHO Expert Advisory Committee publish a global report for governance and oversight of human genome editing.

Françoise Baylis and colleagues from a WHO Expert Advisory Committee publish recommendations on human genome editing.

Françoise Baylis and colleagues from a WHO Expert Advisory Committee publish a position paper on human genome editing.

Françoise Baylis and Sheetal Soni argue against reasons of expediency which would change the 14-day rule for research with human embryos.